# Research and Markets: Practical Biostatistics

Research and Markets (http://www.researchandmarkets.com/research/9xx9v9/practical) has announced the addition of Elsevier Science and Technology's new book "Practical Biostatistics" to their offering.

Evidence-based medicine aims to apply the best available evidence gained from the scientific method to medical decision making. It is a practice that uses statistical analysis of scientific methods and outcomes to drive further experimentation and diagnosis. The profusion of evidence-based medicine in medical practice and clinical research has produced a need for life scientists and clinical researchers to assimilate biostatistics into their work to meet efficacy and practical standards. Practical Biostatistics provides researchers, medical professionals, and students with a friendly, practical guide to biostatistics. With a detailed outline of implementation steps complemented by a review of important topics, this book can be used as a quick reference or a hands-on guide to effectively incorporate biostatistics in clinical trials.

Key Features:

- Customized presentation for biological investigators with examples taken from current clinical trials in multiple disciplines

- Clear and concise definitions and examples provide a pragmatic guide to bring clarity to the applications of statistics in improving human health

- Addresses the challenge of assimilation of mathematical concepts to better interpret literature, to build stronger studies, to present research effectively, and to improve communication with supporting biostatisticians

Topics Covered:

PART 1

STUDY TYPE DETERMINATION

1. Epidemiological studies

2. Analytical studies

3. Summary

PART 2

OBSERVATIONAL STUDIES

4. Determination of association strength between an exposure factor and an event in observational studies

5. Increasing accuracy in observational studies

PART 3

STEP-BY-STEP BIOSTATISTICS OF A CLINICAL TRIAL

6. STEP 1: Investigator's hypothesis and expression of its corresponding outcome

7. STEP 2: n estimation and n assessment of a published trial

8. STEP 3: Organization of variables and endpoints

9. STEP 4: Measures for results expression of a clinical trial

10. STEP 5: Determination of normality or non-normality of data distribution

11. STEP 6: Hypothesis testing

12. STEP 7: Correlating sample data with the general population 95% confidence Interval

PART 4

13. Individual and collective benefit and risk indexes inferable from intervention cohort studies

14. Statistical assessment of diagnostic tests for the clinic

15. Systematic reviews and meta-analyses

16. Correlation and regression

17. Per protocol analysis and intention to treat analysis

Self-evaluation Annotated answers Microsoft Excel 2010

Basics References

Glossary

Index

Authors

Suchmacher, Mendel

Geller, Mauro

Source: Elsevier Science and Technology

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Biotechnology, Mathematics

View Comments and Join the Discussion!

 1 AMRI, CTIC: 20 Stocks Moving In Friday's Pre-Market Session 2 BABA, TSLA: How Tencent, The 'Chinese Facebook,' Compares To I... 3 FL, HIBB: 8 Stocks To Watch For August 18, 2017 4 AMAT, ROST: 5 Biggest Price Target Changes For Friday 5 CBI, CB: Lightning Round: Jim Cramer Weighs... 6 MYGN, BC: Benzinga's Top Upgrade... 7 TGT, URBN: Cramer: These 3 Re...
 1 TWTR, GOOG: A Handy Guide For What The Careful CEO Should, And Shouldn't, Tal... 2 AAPL: Gene Munster Thanks Mom And Dad's Christmas Gift For Launchin... 3 Police Intercept Drone Delivery Of Drugs, Cell Phone At A Michigan... 4 GRMN, FIT: What's Trending In Emerging Tech: 4K TVs, Smart Spea... 5 DIA, TLT: There Is Room For Bonds In Every Portfolio 6 UNH, FB: Cramer Finds A Way To Explain Stock Divers... 7 F, AMZN: Apple, Amazon, Tesla And The Changi...